(CHWY) Chewy - Ratings and Ratios
Pet Food, Pet Supplies, Pet Medications, Pet Services
CHWY EPS (Earnings per Share)
CHWY Revenue
Description: CHWY Chewy
Chewy Inc (NYSE:CHWY) is an e-commerce company specializing in pet products and services, operating primarily in the United States. The company offers a wide range of products, including pet food, treats, supplies, medications, and other health-related products, as well as various pet services. Chewys business model is centered around its online retail platform, accessible through its websites and mobile applications, with a notable feature being its Autoship subscription program, which likely contributes to customer retention and recurring revenue.
From a growth perspective, Chewy has demonstrated significant expansion since its founding in 2010. The pet industry is known for its resilience and growth potential, driven by increasing pet humanization and spending on pet health and wellness. Key Performance Indicators (KPIs) that could be of interest include sales growth rate, customer acquisition cost, customer lifetime value, and the percentage of revenue from subscription services like Autoship. These metrics can provide insights into the companys operational efficiency, customer loyalty, and future revenue predictability.
Analyzing Chewys financial health and valuation, we can observe that the company has a substantial market capitalization of $16 billion. The Price-to-Earnings (P/E) ratio of 42.60 and a forward P/E of 33.33 suggest that the stock is priced at a premium relative to its current and expected earnings. The Return on Equity (RoE) of 115.27% is exceptionally high, indicating strong profitability relative to shareholder equity. Other important financial KPIs to consider would include revenue growth, gross margin, operating margin, and free cash flow, as these can provide a more comprehensive view of the companys profitability, operational efficiency, and ability to generate cash.
To further evaluate Chewys stock, its essential to consider its competitive position within the e-commerce pet products market. Factors such as market share, brand loyalty, and the competitive landscape can influence the companys long-term success. Additionally, examining the companys strategic initiatives, such as expansion into new markets or services, can offer insights into its growth prospects. Understanding these dynamics can help in assessing whether Chewys current valuation is justified by its underlying business performance and future potential.
CHWY Stock Overview
| Market Cap in USD | 14,779m |
| Sector | Consumer Cyclical |
| Industry | Internet Retail |
| GiC Sub-Industry | Other Specialty Retail |
| IPO / Inception | 2019-06-14 |
CHWY Stock Ratings
| Growth Rating | -19.6 |
| Fundamental | 73.5% |
| Dividend Rating | - |
| Rel. Strength | 25.4 |
| Analysts | 3.90 of 5 |
| Fair Price Momentum | 32.95 USD |
| Fair Price DCF | 17.87 USD |
CHWY Dividends
Currently no dividends paidCHWY Growth Ratios
| Growth Correlation 3m | -76.6% |
| Growth Correlation 12m | 81.2% |
| Growth Correlation 5y | -71.9% |
| CAGR 5y | -7.52% |
| CAGR/Max DD 5y | -0.09 |
| Sharpe Ratio 12m | 0.94 |
| Alpha | 25.36 |
| Beta | 1.315 |
| Volatility | 43.39% |
| Current Volume | 6867.4k |
| Average Volume 20d | 5739.9k |
| Stop Loss | 34.7 (-3.9%) |
As of August 10, 2025, the stock is trading at USD 36.12 with a total of 6,867,374 shares traded.
Over the past week, the price has changed by +0.58%, over one month by -9.70%, over three months by -5.54% and over the past year by +52.41%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Chewy (NYSE:CHWY) is currently (August 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 73.53 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CHWY is around 32.95 USD . This means that CHWY is currently overvalued and has a potential downside of -8.78%.
Chewy has received a consensus analysts rating of 3.90. Therefore, it is recommended to buy CHWY.
- Strong Buy: 11
- Buy: 6
- Hold: 12
- Sell: 1
- Strong Sell: 0
According to our own proprietary Forecast Model, CHWY Chewy will be worth about 37.6 in August 2026. The stock is currently trading at 36.12. This means that the stock has a potential upside of +4.21%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 46.1 | 27.6% |
| Analysts Target Price | 45 | 24.6% |
| ValueRay Target Price | 37.6 | 4.2% |
Piotroski VR‑10 (Strict) 8.0
| Net Income (388.2m TTM) > 0 and > 6% of Revenue (6% = 726.0m TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA 6.26pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -3.54% (prev 1.16%; Δ -4.70pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 600.8m > Net Income 388.2m (YES >=105%, WARN >=100%) |
| Net Debt (-116.2m) to EBITDA (272.6m) ratio: -0.43 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.80 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (425.3m) change vs 12m ago -2.55% (target <= -2.0% for YES) |
| Gross Margin 29.24% (prev 28.21%; Δ 1.03pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 386.5% (prev 351.2%; Δ 35.33pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 28.57 (EBITDA TTM 272.6m / Interest Expense TTM 5.48m) >= 6 (WARN >= 3) |
Altman Z'' -2.79
| (A) -0.14 = (Total Current Assets 1.71b - Total Current Liabilities 2.14b) / Total Assets 3.06b |
| (B) -0.50 = Retained Earnings (Balance) -1.52b / Total Assets 3.06b |
| (C) 0.05 = EBIT TTM 156.7m / Avg Total Assets 3.13b |
| (D) -0.56 = Book Value of Equity -1.52b / Total Liabilities 2.68b |
| Total Rating: -2.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay Score 73.53
| 1. Piotroski 8.0pt = 3.0 |
| 2. FCF Yield 2.66% = 1.33 |
| 3. FCF Margin 3.71% = 0.62 |
| 4. Debt/Equity 7.15 = -2.50 |
| 5. Debt/Ebitda 9.85 = -2.50 |
| 6. ROIC - WACC 11.62% = 10.0 |
| 7. RoE 115.3% = 5.0 |
| 8. Rev. Trend 91.42% = 5.0 |
| 9. Rev. CAGR 8.63% = 1.08 |
| 11. EPS CAGR 91.29% = 2.50 |
CHWY Fundamental Data Overview
CCE Cash And Equivalents = 616.4m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 39.3407
P/E Forward = 29.6736
P/S = 1.2214
P/B = 38.1821
P/EG = 1.566
Beta = 1.671
Revenue TTM = 12.10b USD
EBIT TTM = 156.7m USD
EBITDA TTM = 272.6m USD
Long Term Debt = 544.5m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 2.14b USD (from totalCurrentLiabilities, last quarter)
Debt = 2.68b USD (Calculated: Short Term 2.14b + Long Term 544.5m)
Net Debt = -116.2m USD (from netDebt column, last quarter)
Enterprise Value = 16.85b USD (14.78b + Debt 2.68b - CCE 616.4m)
Interest Coverage Ratio = 28.57 (Ebit TTM 156.7m / Interest Expense TTM 5.48m)
FCF Yield = 2.66% (FCF TTM 448.6m / Enterprise Value 16.85b)
FCF Margin = 3.71% (FCF TTM 448.6m / Revenue TTM 12.10b)
Net Margin = 3.21% (Net Income TTM 388.2m / Revenue TTM 12.10b)
Gross Margin = 29.24% ((Revenue TTM 12.10b - Cost of Revenue TTM 8.56b) / Revenue TTM)
[93m Tobins Q-Ratio = -11.11 (set to none) (Enterprise Value 16.85b / Book Value Of Equity -1.52b)
[39m Interest Expense / Debt = 0.05% (Interest Expense 1.30m / Debt 2.68b)
[93m Taxrate = -158.9% (set to none) (from yearly Income Tax Expense: -241.0m / 151.7m)
[39m[93m NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
[39m Current Ratio = 0.80 (Total Current Assets 1.71b / Total Current Liabilities 2.14b)
Debt / Equity = 7.15 (Debt 2.68b / last Quarter total Stockholder Equity 375.6m)
Debt / EBITDA = 9.85 (Net Debt -116.2m / EBITDA 272.6m)
Debt / FCF = 5.99 (Debt 2.68b / FCF TTM 448.6m)
Total Stockholder Equity = 336.8m (last 4 quarters mean)
RoA = 12.69% (Net Income 388.2m, Total Assets 3.06b )
RoE = 115.3% (Net Income TTM 388.2m / Total Stockholder Equity 336.8m)
RoCE = 17.78% (Ebit 156.7m / (Equity 336.8m + L.T.Debt 544.5m))
RoIC = 11.62% (Ebit 156.7m / (Assets 3.06b - Current Assets 1.71b))
[93m WACC = unknown (E(14.78b)/V(17.46b) * Re(10.86%)) + (D(2.68b)/V(17.46b) * Rd(0.05%) * (1-Tc(none)))
[39m Shares Correlation 5-Years: 10.0 | Cagr: 0.35%
Discount Rate = 10.86% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 67.47% ; FCFE base≈376.6m ; Y1≈360.0m ; Y5≈348.3m
Fair Price DCF = 17.87 (DCF Value 3.99b / Shares Outstanding 223.1m; 5y FCF grow -5.81% → 2.90% )
Revenue Correlation: 91.42 | Revenue CAGR: 8.63%
Revenue Growth Correlation: -8.42%
EPS Correlation: N/A | EPS CAGR: 91.29%
EPS Growth Correlation: 26.02%
Additional Sources for CHWY Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle